United States Biotechnology & Medical Research

Vanda Pharmaceuticals Inc (VNDA)

Track

The most recent insider trading activity occurred on March 2, 2026, with multiple executives, including the President and CEO, SVP of Finance, and SVP of Business Development, engaging in significant proposed sales and actual sales. Prior to this, on February 23, 2026, a Director also made a proposed sale and an actual sale. The last reported buy transaction was on August 7, 2025.
Ticker: VNDA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Vanda Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Moran Kevin Patrick
SVP, CFO & Treasurer
1 sale — total 350,821 USD
Sale 2 Mar 2026
Value US$4,260,855.52 | Price 66.10 | Shares 28,594
Sale 2 Mar 2026
Value US$3,974,635.29 | Price 377.03 | Shares 95,191
Sale 2 Mar 2026
Value US$254,589.72 | Price 8.27 | Shares 30,800
Sale 2 Mar 2026
Value US$1,276,971.15 | Price 8.17 | Shares 156,235
Sale 2 Mar 2026
Value US$350,730.40 | Price 8.27 | Shares 42,431
Proposed sale 2 Mar 2026
Value US$350,755.00 | Price 8.27 | Shares 42,434
Proposed sale 2 Mar 2026
Value US$350,730.00 | Price 8.27 | Shares 42,431
Proposed sale 2 Mar 2026
Value US$254,589.00 | Price 8.27 | Shares 30,800
Proposed sale 2 Mar 2026
Value US$1,276,976.00 | Price 8.17 | Shares 156,235
Proposed sale 2 Mar 2026
Value US$350,821.00 | Price 8.27 | Shares 42,442
Sale 23 Feb 2026
Value US$240,900.00 | Price 8.03 | Shares 30,000
Proposed sale 23 Feb 2026
Value US$240,900.00 | Price 8.03 | Shares 30,000
Buy 7 Aug 2025
Value US$41,500.00 | Price 4.15 | Shares 10,000
Sale 13 Jun 2025
Value US$32,130.00 | Price 4.59 | Shares 7,000
Proposed sale 13 Jun 2025
Value US$32,159.00 | Price 4.59 | Shares 7,000
Buy 21 May 2025
Value US$2,111.59 | Price 4.39 | Shares 481
Buy 21 May 2025
Value US$41,883.60 | Price 4.40 | Shares 9,519
Buy 16 May 2025
Value US$84,472.00 | Price 4.22 | Shares 20,000
Buy 6 Mar 2025
Value US$25,050.00 | Price 5.01 | Shares 5,000
Buy 6 Mar 2025
Value US$25,100.00 | Price 5.02 | Shares 5,000
Buy 5 Mar 2025
Value US$25,150.00 | Price 5.03 | Shares 5,000
Buy 5 Mar 2025
Value US$25,050.00 | Price 5.01 | Shares 5,000
Buy 3 Mar 2025
Value US$47,050.00 | Price 4.71 | Shares 10,000
Buy 28 Feb 2025
Value US$47,600.00 | Price 4.76 | Shares 10,000
Buy 27 Feb 2025
Value US$47,600.00 | Price 4.76 | Shares 10,000
Buy 26 Feb 2025
Value US$23,900.00 | Price 4.78 | Shares 5,000
Buy 26 Feb 2025
Value US$23,750.00 | Price 4.75 | Shares 5,000
Buy 25 Feb 2025
Value US$44,640.00 | Price 4.46 | Shares 10,000
Buy 21 Feb 2025
Value US$8,778.80 | Price 4.39 | Shares 2,000
Sale 14 Nov 2024
Value US$25,863.00 | Price 5.17 | Shares 5,000
Proposed sale 14 Nov 2024
Value US$27,000.00 | Price 5.40 | Shares 5,000
Proposed sale 29 Jul 2024
Value US$13,327.00 | Price 5.92 | Shares 2,251
Sale 29 Jul 2024
Value US$13,326.60 | Price 5.92 | Shares 2,251
Sale 5 Mar 2024
Value US$37,395.73 | Price 4.18 | Shares 8,941
Sale 5 Mar 2024
Value US$35,884.02 | Price 4.13 | Shares 8,684
Sale 5 Mar 2024
Value US$100,273.01 | Price 4.13 | Shares 24,288
Sale 5 Mar 2024
Value US$38,830.09 | Price 4.21 | Shares 9,229
Sale 5 Mar 2024
Value US$37,410.66 | Price 4.20 | Shares 8,902
Sale 4 Mar 2024
Value US$35,916.86 | Price 4.41 | Shares 8,147
Proposed sale 4 Mar 2024
Value US$147,635.00 | Price 4.61 | Shares 32,025
Sale 4 Mar 2024
Value US$37,494.68 | Price 4.30 | Shares 8,727
Proposed sale 4 Mar 2024
Value US$147,635.00 | Price 4.61 | Shares 32,025
Sale 4 Mar 2024
Value US$131,065.52 | Price 4.24 | Shares 30,884
Sale 4 Mar 2024
Value US$33,090.92 | Price 4.41 | Shares 7,498
Proposed sale 4 Mar 2024
Value US$139,683.00 | Price 4.61 | Shares 30,300
Sale 4 Mar 2024
Value US$25,982.00 | Price 4.48 | Shares 5,798
Proposed sale 4 Mar 2024
Value US$127,646.00 | Price 4.61 | Shares 27,689
Proposed sale 4 Mar 2024
Value US$466,763.00 | Price 4.61 | Shares 101,250
Sale 21 Aug 2023
Value US$21,748.16 | Price 5.84 | Shares 3,724
Proposed sale 21 Aug 2023
Value US$21,748.00 | Price 5.84 | Shares 3,724
Sale 10 Aug 2023
Value US$39,349.05 | Price 6.05 | Shares 6,500
Proposed sale 10 Aug 2023
Value US$39,349.00 | Price 6.05 | Shares 6,500
Sale 28 Jul 2023
Value US$11,349.00 | Price 6.31 | Shares 1,800
Sale 28 Jul 2023
Value US$2,595.60 | Price 6.30 | Shares 412
Proposed sale 28 Jul 2023
Value US$13,945.00 | Price 6.30 | Shares 2,212
Sale 15 Jun 2023
Value US$100,710.40 | Price 6.29 | Shares 16,000
Proposed sale 15 Jun 2023
Value US$106,667.00 | Price 6.67 | Shares 16,000
Sale 13 Jun 2023
Value US$95,754.10 | Price 6.56 | Shares 14,600
Proposed sale 13 Jun 2023
Value US$96,360.00 | Price 6.60 | Shares 14,600
Sale 3 Mar 2023
Value US$25,994.16 | Price 6.32 | Shares 4,113
Sale 3 Mar 2023
Value US$51,887.06 | Price 6.25 | Shares 8,301
Sale 3 Mar 2023
Value US$51,790.75 | Price 6.26 | Shares 8,268
Sale 3 Mar 2023
Value US$140,876.02 | Price 6.25 | Shares 22,538
Sale 3 Mar 2023
Value US$37,498.73 | Price 6.28 | Shares 5,968
Sale 2 Mar 2023
Value US$48,122.62 | Price 6.23 | Shares 7,720
Sale 2 Mar 2023
Value US$52,684.85 | Price 6.24 | Shares 8,437
Sale 2 Mar 2023
Value US$52,793.24 | Price 6.20 | Shares 8,509
Sale 2 Mar 2023
Value US$139,718.47 | Price 6.23 | Shares 22,426
Sale 2 Mar 2023
Value US$49,845.65 | Price 6.26 | Shares 7,966
Sale 15 Dec 2022
Value US$56,069.60 | Price 7.01 | Shares 8,000
Sale 6 Dec 2022
Value US$512,082.08 | Price 10.61 | Shares 48,250
Sale 6 Dec 2022
Value US$50,826.83 | Price 10.61 | Shares 4,792
Sale 5 Dec 2022
Value US$506,200.24 | Price 10.62 | Shares 47,650
Sale 22 Aug 2022
Value US$37,007.49 | Price 10.27 | Shares 3,605
Sale 15 Aug 2022
Value US$47,064.94 | Price 10.21 | Shares 4,611
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-04 2026-03-02 S Sale
3.3
Moran Kevin Patrick

SVP, CFO & Treasurer

Officer
28,594 -39.6%
66.10
US$4,260,856 		28,594 -39.6% 66.10 US$4,260,856
2026-03-04 2026-03-02 S Sale
3.7
Williams Timothy

SVP & General Counsel

Officer
95,191 -3.2%
377.03
US$3,974,635 		95,191 -3.2% 377.03 US$3,974,635
2026-03-04 2026-03-02 S Sale
3.7
Wijkstrom Joakim

SVP, Chief Marketing Officer

Officer
32,513 +31.0%
264.61
US$1,246,493 		32,513 +31.0% 264.61 US$1,246,493
2026-03-04 2026-03-02 S Sale
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
156,235 -5.5%
8.17
US$1,276,971 		156,235 -5.5% 8.17 US$1,276,971
2026-03-04 2026-03-02 S Sale
3.8
Birznieks Gunther

SVP, Business Development

Officer
42,431 -7.9%
8.27
US$350,730 		42,431 -7.9% 8.27 US$350,730
2026-03-02 2026-03-02 PrS Proposed sale
3.7
Timothy Williams

SVP & General Counsel
42,434
8.27
US$350,755 		42,434 8.27 US$350,755
2026-03-02 2026-03-02 PrS Proposed sale
3.8
Gunther Birznieks

SVP, Business Development
42,431
8.27
US$350,730 		42,431 8.27 US$350,730
2026-03-02 2026-03-02 PrS Proposed sale
3.7
Joakim Wijkstrom

SVP, Chief Marketing Officer

Officer
30,800
8.27
US$254,589 		30,800 8.27 US$254,589
2026-03-02 2026-03-02 PrS Proposed sale
3.2
Mihael H. Polymeropoulos

Officer; Chairman of the Board

Officer
156,235
8.17
US$1,276,976 		156,235 8.17 US$1,276,976
2026-03-02 2026-03-02 PrS Proposed sale
3.3
Kevin Moran

SVP, CFO & Treasurer
42,442
8.27
US$350,821 		42,442 8.27 US$350,821
2026-02-24 2026-02-23 S Sale
3.2
Honore Tage
Non-Executive Director
30,000 -24.3%
8.03
US$240,900 		30,000 -24.3% 8.03 US$240,900
2026-02-23 2026-02-23 PrS Proposed sale
3.2
Honore Tage

Director

Non-Executive Director
30,000
8.03
US$240,900 		30,000 8.03 US$240,900
2025-08-08 2025-08-07 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
10,000 +0.4%
4.15
US$41,500 		10,000 +0.4% 4.15 US$41,500
2025-06-16 2025-06-13 S Sale
3.2
Mitchell Stephen Ray
Non-Executive Director
7,000 -6.7%
4.59
US$32,130 		7,000 -6.7% 4.59 US$32,130
2025-06-13 2025-06-13 PrS Proposed sale
3.2
Mitchell Stephen Ray

Director

Non-Executive Director
7,000
4.59
US$32,159 		7,000 4.59 US$32,159
2025-05-21 2025-05-21 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
481 +0.0%
4.39
US$2,112 		481 +0.0% 4.39 US$2,112
2025-05-21 2025-05-21 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
9,519 +0.4%
4.40
US$41,884 		9,519 +0.4% 4.40 US$41,884
2025-05-19 2025-05-16 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
20,000 +0.9%
4.22
US$84,472 		20,000 +0.9% 4.22 US$84,472
2025-03-06 2025-03-06 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
5,000 +0.2%
5.01
US$25,050 		5,000 +0.2% 5.01 US$25,050
2025-03-06 2025-03-06 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
5,000 +0.2%
5.02
US$25,100 		5,000 +0.2% 5.02 US$25,100
2025-03-05 2025-03-05 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
5,000 +0.2%
5.03
US$25,150 		5,000 +0.2% 5.03 US$25,150
2025-03-05 2025-03-05 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
5,000 +0.2%
5.01
US$25,050 		5,000 +0.2% 5.01 US$25,050
2025-03-04 2025-03-03 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
10,000 +0.4%
4.71
US$47,050 		10,000 +0.4% 4.71 US$47,050
2025-02-28 2025-02-28 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
10,000 +0.4%
4.76
US$47,600 		10,000 +0.4% 4.76 US$47,600
2025-02-27 2025-02-27 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
10,000 +0.4%
4.76
US$47,600 		10,000 +0.4% 4.76 US$47,600
2025-02-26 2025-02-26 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
5,000 +0.2%
4.78
US$23,900 		5,000 +0.2% 4.78 US$23,900
2025-02-26 2025-02-26 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
5,000 +0.2%
4.75
US$23,750 		5,000 +0.2% 4.75 US$23,750
2025-02-25 2025-02-25 B Purchase
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
10,000 +0.4%
4.46
US$44,640 		10,000 +0.4% 4.46 US$44,640
2025-02-24 2025-02-21 B Purchase
3.3
Moran Kevin Patrick

SVP, CFO & Treasurer

Officer
2,000 +0.6%
4.39
US$8,779 		2,000 +0.6% 4.39 US$8,779
2024-11-18 2024-11-14 S Sale
3.2
Mitchell Stephen Ray
Non-Executive Director
5,000 -10.0%
5.17
US$25,863 		5,000 -10.0% 5.17 US$25,863
2024-11-14 2024-11-14 PrS Proposed sale
3.2
Mitchell Stephen Ray

Director

Non-Executive Director
5,000
5.40
US$27,000 		5,000 5.40 US$27,000
2024-07-29 2024-07-29 PrS Proposed sale
3.3
Moran Kevin Patrick

Officer

Officer
2,251
5.92
US$13,327 		2,251 5.92 US$13,327
2024-07-29 2024-07-29 S Sale
3.3
Moran Kevin Patrick

SVP, CFO & Treasurer

Officer
2,251 -1.0%
5.92
US$13,327 		2,251 -1.0% 5.92 US$13,327
2024-03-06 2024-03-05 S Sale
3.7
Williams Timothy

SVP & General Counsel

Officer
8,941 -4.3%
4.18
US$37,396 		8,941 -4.3% 4.18 US$37,396
2024-03-06 2024-03-05 S Sale
3.8
Birznieks Gunther

SVP, Business Development

Officer
8,684 -2.7%
4.13
US$35,884 		8,684 -2.7% 4.13 US$35,884
2024-03-06 2024-03-05 S Sale
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
24,288 -1.3%
4.13
US$100,273 		24,288 -1.3% 4.13 US$100,273
2024-03-06 2024-03-05 S Sale
3.7
Wijkstrom Joakim

SVP, Chief Marketing Officer

Officer
9,229 -6.6%
4.21
US$38,830 		9,229 -6.6% 4.21 US$38,830
2024-03-06 2024-03-05 S Sale
3.3
Moran Kevin Patrick

SVP, CFO & Treasurer

Officer
8,902 -3.7%
4.20
US$37,411 		8,902 -3.7% 4.20 US$37,411
2024-03-06 2024-03-04 S Sale
3.7
Williams Timothy

SVP & General Counsel

Officer
8,147 -3.8%
4.41
US$35,917 		8,147 -3.8% 4.41 US$35,917
2024-03-06 2024-03-04 S Sale
3.8
Birznieks Gunther

SVP, Business Development

Officer
8,727 -2.6%
4.30
US$37,495 		8,727 -2.6% 4.30 US$37,495
2024-03-06 2024-03-04 S Sale
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
30,884 -1.6%
4.24
US$131,066 		30,884 -1.6% 4.24 US$131,066
2024-03-06 2024-03-04 S Sale
3.7
Wijkstrom Joakim

SVP, Chief Marketing Officer

Officer
7,498 -5.1%
4.41
US$33,091 		7,498 -5.1% 4.41 US$33,091
2024-03-06 2024-03-04 S Sale
3.3
Moran Kevin Patrick

SVP, CFO & Treasurer

Officer
5,798 -2.4%
4.48
US$25,982 		5,798 -2.4% 4.48 US$25,982
2024-03-04 2024-03-04 PrS Proposed sale
3.7
Williams Timothy

Officer

Officer
32,025
4.61
US$147,635 		32,025 4.61 US$147,635
2024-03-04 2024-03-04 PrS Proposed sale
3.7
Wijkstrom Joakim

Officer

Officer
30,300
4.61
US$139,683 		30,300 4.61 US$139,683
2024-03-04 2024-03-04 PrS Proposed sale
3.2
Polymeropoulos Mihael Hristos

Officer; Director; Chairman of the Board

Executive Director
101,250
4.61
US$466,763 		101,250 4.61 US$466,763
2024-03-04 2024-03-04 PrS Proposed sale
3.3
Moran Kevin Patrick

Officer

Officer
27,689
4.61
US$127,646 		27,689 4.61 US$127,646
2024-03-04 2024-03-04 PrS Proposed sale
3.8
Birznieks Gunther

Officer

Officer
32,025
4.61
US$147,635 		32,025 4.61 US$147,635
2023-08-23 2023-08-21 S Sale
3.7
Wijkstrom Joakim

SVP, Chief Marketing Officer

Officer
3,724 -3.2%
5.84
US$21,748 		3,724 -3.2% 5.84 US$21,748
2023-08-21 2023-08-21 PrS Proposed sale
3.7
Wijkstrom Joakim

Officer

Officer
3,724
5.84
US$21,748 		3,724 5.84 US$21,748
2023-08-11 2023-08-10 S Sale
3.2
Mitchell Stephen Ray
Non-Executive Director
6,500 -18.1%
6.05
US$39,349 		6,500 -18.1% 6.05 US$39,349
2023-08-10 2023-08-10 PrS Proposed sale
3.2
Mitchell Stephen Ray

Director

Non-Executive Director
6,500
6.05
US$39,349 		6,500 6.05 US$39,349
2023-08-01 2023-07-28 S Sale
3.3
Moran Kevin Patrick

SVP, CFO & Treasurer

Officer
1,800 -1.5%
6.31
US$11,349 		1,800 -1.5% 6.31 US$11,349
2023-08-01 2023-07-28 S Sale
3.3
Moran Kevin Patrick

SVP, CFO & Treasurer

Officer
412 -0.3%
6.30
US$2,596 		412 -0.3% 6.30 US$2,596
2023-07-28 2023-07-28 PrS Proposed sale
3.3
Moran Kevin Patrick

Officer

Officer
2,212
6.30
US$13,945 		2,212 6.30 US$13,945
2023-06-20 2023-06-15 S Sale
3.3
Moran Kevin Patrick

SVP, CFO & Treasurer

Officer
16,000 -11.5%
6.29
US$100,710 		16,000 -11.5% 6.29 US$100,710
2023-06-15 2023-06-15 PrS Proposed sale
3.3
Moran Kevin Patrick

Officer

Officer
16,000
6.67
US$106,667 		16,000 6.67 US$106,667
2023-06-15 2023-06-13 S Sale
3.7
Williams Timothy

SVP & General Counsel

Officer
14,600 -14.1%
6.56
US$95,754 		14,600 -14.1% 6.56 US$95,754
2023-06-13 2023-06-13 PrS Proposed sale
3.7
Williams Timothy

Officer

Officer
14,600
6.60
US$96,360 		14,600 6.60 US$96,360
2023-03-06 2023-03-03 S Sale
3.7
Wijkstrom Joakim

SVP, Chief Marketing Officer

Officer
4,113 -3.4%
6.32
US$25,994 		4,113 -3.4% 6.32 US$25,994
2023-03-06 2023-03-03 S Sale
3.7
Williams Timothy

SVP & General Counsel

Officer
8,301 -7.4%
6.25
US$51,887 		8,301 -7.4% 6.25 US$51,887
2023-03-06 2023-03-03 S Sale
3.8
Birznieks Gunther

SVP, Business Development

Officer
8,268 -3.9%
6.26
US$51,791 		8,268 -3.9% 6.26 US$51,791
2023-03-06 2023-03-03 S Sale
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
22,538 -1.5%
6.25
US$140,876 		22,538 -1.5% 6.25 US$140,876
2023-03-06 2023-03-03 S Sale
3.3
Moran Kevin Patrick

SVP, CFO & Treasurer

Officer
5,968 -4.1%
6.28
US$37,499 		5,968 -4.1% 6.28 US$37,499
2023-03-06 2023-03-02 S Sale
3.7
Wijkstrom Joakim

SVP, Chief Marketing Officer

Officer
7,720 -6.0%
6.23
US$48,123 		7,720 -6.0% 6.23 US$48,123
2023-03-06 2023-03-02 S Sale
3.7
Williams Timothy

SVP & General Counsel

Officer
8,437 -7.0%
6.24
US$52,685 		8,437 -7.0% 6.24 US$52,685
2023-03-06 2023-03-02 S Sale
3.8
Birznieks Gunther

SVP, Business Development

Officer
8,509 -3.8%
6.20
US$52,793 		8,509 -3.8% 6.20 US$52,793
2023-03-06 2023-03-02 S Sale
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
22,426 -1.5%
6.23
US$139,718 		22,426 -1.5% 6.23 US$139,718
2023-03-06 2023-03-02 S Sale
3.3
Moran Kevin Patrick

SVP, CFO & Treasurer

Officer
7,966 -5.2%
6.26
US$49,846 		7,966 -5.2% 6.26 US$49,846
2022-12-16 2022-12-15 S Sale
3.7
Williams Timothy

SVP & General Counsel

Officer
8,000 -8.4%
7.01
US$56,070 		8,000 -8.4% 7.01 US$56,070
2022-12-07 2022-12-06 S Sale
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
48,250 -3.3%
10.61
US$512,082 		48,250 -3.3% 10.61 US$512,082
2022-12-07 2022-12-06 S Sale
3.3
Moran Kevin Patrick

SVP, CFO & Treasurer

Officer
4,792 -3.8%
10.61
US$50,827 		4,792 -3.8% 10.61 US$50,827
2022-12-07 2022-12-05 S Sale
3.2
Polymeropoulos Mihael Hristos

President and CEO

Executive Director
47,650 -3.3%
10.62
US$506,200 		47,650 -3.3% 10.62 US$506,200
2022-08-23 2022-08-22 S Sale
3.7
Wijkstrom Joakim

SVP, Chief Marketing Officer

Officer
3,605 -3.6%
10.27
US$37,007 		3,605 -3.6% 10.27 US$37,007
2022-08-17 2022-08-15 S Sale
3.7
Williams Timothy

SVP & General Counsel

Officer
4,611 -4.6%
10.21
US$47,065 		4,611 -4.6% 10.21 US$47,065
Explore more

More insider trading research around Vanda Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America